BioCentury | Apr 13, 2009
Company News

Eureka Genomics, Nanobac deal

...into Eureka Genomics Inc. Eureka shareholders will own about 85% of the combined company, and Nanobac...
...genomic sequence data analysis and in silico design of sequence specific PCR and microarray assays. Nanobac...
...calcifying nanoparticles which are associated with heart disease and various cancers but retains all IP. Nanobac's...
BioCentury | Feb 11, 2008
Company News

DNAPrint, Nanobac deal

...The companies signed a letter of intent for Nanobac to acquire pharmacogenetics and consumer genetic test...
...genetic test services company DNAPrint for 75 million shares valued at $3 million based on Nanobac's...
...and genetically modified form of erythropoietin (EPO) that is in preclinical development to treat anemia. Nanobac...
BioCentury | Oct 8, 2007
Company News

Calgenex Corp., Nanobac Life Sciences Inc. deal

...combinations used to treat atherosclerosis, prostatitis and other calcification diseases. Calgenex Corp. , Tampa, Fla. Nanobac...
BioCentury | Apr 4, 2005
Company News

Nanobac Life Sciences Inc. management update

Nanobac Life Sciences Inc. (NNBP), Tampa, Fla. Business: Infectious Promoted: Grant Carlson to president and COO from VP of business development WIR Staff...
BioCentury | Mar 31, 2005
Company News

Nanobac names Carlson COO

NNBP promoted Grant Carlson to president and COO from VP of business development. NNBP is researching the pathogenic role of Nanobacteria in calcification in coronary artery heart disease and vascular disease. BC Staff...
BioCentury | Jan 31, 2005
Company News

Nanobac Life Sciences Inc. other research news

...studies have shown that 100% of kidney cyst fluids and urine were positive for nanobacteria. Nanobac...
BioCentury | Jan 17, 2005
Company News

Nanobac Life Sciences Inc. other research news

...Researchers reported that nanobacteria are associated with the development of atherosclerotic heart disease. Using Nanobac's Nanobacterial...
...heart valves. Also, patients with severe coronary artery heart disease tested positive for nanobacterial antigen. Nanobac...
BioCentury | Dec 13, 2004
Company News

Nanobac Life Sciences Inc. other research news

...ovarian cancer had nanobacteria present, and 100% of uncalcified ovarian cancers did not have nanobacteria. Nanobac...
BioCentury | May 3, 2004
Company News

Nanobac Life Sciences Inc. other research news

...a group of 198 asymptomatic subjects (p=0.017). Nanobac Life Sciences Inc. (NNBP), Tampa, Fla. Product: Nanobac...
BioCentury | Feb 9, 2004
Company News

Nanobac board of directors update

Nanobac Pharmaceuticals Inc. (NNBP), Tampa, Fla. Business: Infectious Appointed: Jan Egberts, chairman and managing director of Molnlycke Healthcare Inc.; and Stephen Rechtschaffen, CEO and chairman at Omega Institute WIR Staff Infectious...
Items per page:
1 - 10 of 11
BioCentury | Apr 13, 2009
Company News

Eureka Genomics, Nanobac deal

...into Eureka Genomics Inc. Eureka shareholders will own about 85% of the combined company, and Nanobac...
...genomic sequence data analysis and in silico design of sequence specific PCR and microarray assays. Nanobac...
...calcifying nanoparticles which are associated with heart disease and various cancers but retains all IP. Nanobac's...
BioCentury | Feb 11, 2008
Company News

DNAPrint, Nanobac deal

...The companies signed a letter of intent for Nanobac to acquire pharmacogenetics and consumer genetic test...
...genetic test services company DNAPrint for 75 million shares valued at $3 million based on Nanobac's...
...and genetically modified form of erythropoietin (EPO) that is in preclinical development to treat anemia. Nanobac...
BioCentury | Oct 8, 2007
Company News

Calgenex Corp., Nanobac Life Sciences Inc. deal

...combinations used to treat atherosclerosis, prostatitis and other calcification diseases. Calgenex Corp. , Tampa, Fla. Nanobac...
BioCentury | Apr 4, 2005
Company News

Nanobac Life Sciences Inc. management update

Nanobac Life Sciences Inc. (NNBP), Tampa, Fla. Business: Infectious Promoted: Grant Carlson to president and COO from VP of business development WIR Staff...
BioCentury | Mar 31, 2005
Company News

Nanobac names Carlson COO

NNBP promoted Grant Carlson to president and COO from VP of business development. NNBP is researching the pathogenic role of Nanobacteria in calcification in coronary artery heart disease and vascular disease. BC Staff...
BioCentury | Jan 31, 2005
Company News

Nanobac Life Sciences Inc. other research news

...studies have shown that 100% of kidney cyst fluids and urine were positive for nanobacteria. Nanobac...
BioCentury | Jan 17, 2005
Company News

Nanobac Life Sciences Inc. other research news

...Researchers reported that nanobacteria are associated with the development of atherosclerotic heart disease. Using Nanobac's Nanobacterial...
...heart valves. Also, patients with severe coronary artery heart disease tested positive for nanobacterial antigen. Nanobac...
BioCentury | Dec 13, 2004
Company News

Nanobac Life Sciences Inc. other research news

...ovarian cancer had nanobacteria present, and 100% of uncalcified ovarian cancers did not have nanobacteria. Nanobac...
BioCentury | May 3, 2004
Company News

Nanobac Life Sciences Inc. other research news

...a group of 198 asymptomatic subjects (p=0.017). Nanobac Life Sciences Inc. (NNBP), Tampa, Fla. Product: Nanobac...
BioCentury | Feb 9, 2004
Company News

Nanobac board of directors update

Nanobac Pharmaceuticals Inc. (NNBP), Tampa, Fla. Business: Infectious Appointed: Jan Egberts, chairman and managing director of Molnlycke Healthcare Inc.; and Stephen Rechtschaffen, CEO and chairman at Omega Institute WIR Staff Infectious...
Items per page:
1 - 10 of 11